Abstract:Background: Laparoscopic distal gastrectomy with D2 lymphadenectomy plus complete mesogastric excision (D2+CME), proposed as a novel strategy and optional procedure in the surgical treatment of advanced gastric cancer (AGC), exhibited both surgical and oncological benefits. However, it lacks strong evidence regarding its surgical safety and oncologic efficacy. Here, we conducted a single-center, prospective, randomized controlled trial to compare laparoscopic D2+CME with conventional laparoscopic D2 lymphadenectomy for AGC. Methods: Patients aged 18 to 75 year-old with locally AGC were considered eligible. Patients were excluded due to high body mass index (>30kg/m2), combination with other tumors, preoperative chemo/radiotherapy or upper-abdominal operations history. Eligible patients were randomly (1:1) assigned to laparoscopic distal gastrectomy with D2+CME (D2+CME group) or conventional D2 lymphadenectomy (D2 group) by an independent data collecting group. The primary end-point was 3-year disease-free survival. The current interim analysis reported the surgical outcomes of the trial. Findings: Between September 2014 and June 2018, a total of 338 patients were randomly assigned to either the D2+CME or D2 group (D2+CME, 169 patients; D2, 169 patients). There were no significant differences in age, gender, ASA score or comorbidities between two groups. The postoperative complication rates of the D2+CME group and the D2 group were 20•1% (34/169) and 16•0% (27/169), respectively (p=0•322). Severe complications occurred in the 2 cases of D2 group. The mortality rate was 0% in both groups. Compared with D2 group, D2+CME group showed less intra-laparoscopic bleeding (median 15•0 [interquartile range 23•0] vs. median 37•0 [interquartile range 33•5] ml, p<0•0001) and more lymph node harvesting (median 34 [interquartile range 16] vs. median 27 [interquartile range 13], p<0•010). In the postoperative recovery course, flatus appeared earlier in the D2+CME group compared with the D2 group (p=0•009). Interpretation: Laparoscopic D2+CME exhibited advantages in intra-operative bleeding, lymph nodes harvesting and postoperative flatus duration without increasing morbidity and mortality. Thus, laparoscopic D2+CME appears safer and more effective than conventional D2 for patients with AGC. Trial Registration: This study was registered at ClinicalTrials.gov (NCT01978444). Funding Statement: This work was supported by grants from the National Science Foundation of China, Grant numbers: 81171927, 81372324, 81874185. Declaration of Interests: The authors declare no conflict of interest. Ethics Approval Statement: This trial was approved by the Ethics Committee of Huazhong University of Science and Technology.

What is the Better Choice for T1b Gallbladder Cancer: Simple Versus Extended Cholecystectomy

Surgical Outcomes of Laparoscopic Distal Gastrectomy with D2 Lymphadenectomy Plus Complete Mesogastric Excision (D2+CME) Versus Conventional Laparoscopic D2 Distal Gastrectomy for Locally Advanced Gastric Cancer: Short-Term Analysis of a Single Center, Prospective, Randomized Controlled Trial

Simple cholecystectomy is an adequate treatment for grade I T1bN0M0 gallbladder carcinoma: Evidence from 528 patients

Survival Benefits of Simple Versus Extended Cholecystectomy and Lymphadenectomy for Patients With T2 Gallbladder Cancer: A Propensity-Matched Population-Based Study (2010 to 2015)

Long-Term Oncologic Outcomes for T2 Gallbladder Cancer According to the Type of Surgery Performed and the Optimal Timing for Sequential Extended Cholecystectomy

A 21-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate?

Concurrent Chemoradiotherapy in Curatively Resected Gallbladder Carcinoma: A Propensity Score-Matched Analysis.

Prognostic Effect of Liver Resection in Extended Cholecystectomy for T2 Gallbladder Cancer Revisited: A Retrospective Cohort Study With Propensity Score-matched Analysis

Clinical Outcomes Between a Minimally Invasive and Open Extended Cholecystectomy for T2 Gallbladder Cancer: A Propensity Score Matching Analysis

Laparoscopic versus open treatment of gallbladder cancer: A systematic review and meta-analysis.

Long-term outcomes of surgical resection for T1b gallbladder cancer: an institutional evaluation

Comparative Study of Laparoscopic Versus Open Liver Resection in Gallbladder Cancer

Laparoscopy versus laparotomy approach of a radical resection for gallbladder cancer: a retrospective comparative study

Cost and morbidity of surgical management of resectable gallbladder cancer (GBC): Results from the National Inpatient Sample database.

Comparison of different surgical treatments for early-stage gallbladder cancer

Minimally invasive versus the conventional open surgical approach of a radical cholecystectomy for gallbladder cancer: a retrospective comparative study

Laparoscopic versus open surgery in treating patients with gallbladder cancer: a systematic review and meta-analysis

[Analysis for the short-term efficacy and long-term prognosis of laparoscopic and laparotomy radical resection for gallbladder cancer]

Chemotherapy or chemotherapy followed by consolidation chemoradiation in postoperative (simple cholecystectomy) gall bladder cancer with residual disease, unsuitable for revision surgery? Risk stratification and outcomes

Hepatectomy strategy for T2 gallbladder cancer between segment IVb and V resection and wedge resection: A propensity score-matched study

Laparoscopic versus open oncological extended re-resection for incidental gallbladder adenocarcinoma: we can do more than T1/2